Clinical trial · Interventional
Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
NCT02594943CI-TRIAL-00035933withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Too narrow inclusion criteria. Impossible to recruit patients.
Summary
Brief summary (as posted)
Endodrill is a new instrument for biopsy sampling in the GI-channel. The purpose of this study is as follows: * Compare the Endodrill instrument with conventional biopsy forceps in terms of ability to establish the correct diagnosis of diffuse gastric cancer based on collected biopsies from tumor tissue.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stomach Neoplasms | Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Boston Scientific Large Capacity with needle Biopsy | Device | — | UNRESOLVED |
| Endodrill 1A (BIBBInstruments, Lund, Sweden) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Conventional Biopsy
- description
- 4 out of 8 biopsies taken with a Boston Scientific Large capacity with needle biopsy forceps from the suspected tumor tissue in the stomach. They will be taken in random order "blinded" for the person performing the examination.
- interventionNames
- Device: Boston Scientific Large Capacity with needle Biopsy
- type
- ACTIVE_COMPARATOR
- label
- Endodrill Biopsy
- description
- 4 out of 8 biopsies taken with the Endodrill 1A instrument from the suspected tumor tissue in the stomach. They will be taken in random order "blinded" for the person performing the examination.
- interventionNames
- Device: Endodrill 1A (BIBBInstruments, Lund, Sweden)
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with suspected or with an established diagnosis of diffuse gastric cancer who are capable of stating a formal consent to participate in the study. Exclusion Criteria: * Mental illness * Extreme co-morbidity (ASA\>3)
References
Publications (0)
Data not yet available
No reference posted for this study.